Skin Cancer Vaccine Developed by Tampa Company Enters Phase 1 of Clinical Trial (WFLA.com)

Skin Cancer Vaccine Developed by Tampa Company Enters Phase 1 of Clinical Trial

A skin cancer vaccine developed by a Tampa company is entering “phase one” of clinical trials.

UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc. completed its first-in-human phase one trial in cutaneous melanoma at Moffitt Cancer Center within the past year and has now moved into studying patients in earlier stages of skin cancers.

Read more about Skin Cancer Vaccine Developed by Tampa Company Enters Phase 1 of Clinical Trial.
X